A detailed history of Compagnie Lombard Odier S Cm A transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Compagnie Lombard Odier S Cm A holds 198,246 shares of TMO stock, worth $122 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares
198,246
Previous 202,876 2.28%
Holding current value
$122 Million
Previous $118 Million 7.02%
% of portfolio
1.94%
Previous 2.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

SELL
$541.52 - $599.02 $2.51 Million - $2.77 Million
-4,630 Reduced 2.28%
198,246 $110 Million
Q1 2024

May 01, 2024

BUY
$528.82 - $599.43 $4.31 Million - $4.89 Million
8,155 Added 4.19%
202,876 $118 Million
Q4 2023

Jan 16, 2024

SELL
$431.41 - $532.94 $3.95 Million - $4.88 Million
-9,161 Reduced 4.49%
194,721 $103 Million
Q3 2023

Oct 23, 2023

BUY
$498.29 - $574.41 $7.09 Million - $8.17 Million
14,221 Added 7.5%
203,882 $103 Million
Q2 2023

Aug 07, 2023

SELL
$508.46 - $591.13 $3.87 Million - $4.5 Million
-7,607 Reduced 3.86%
189,661 $99 Million
Q1 2023

May 01, 2023

SELL
$535.0 - $604.82 $11 Million - $12.5 Million
-20,613 Reduced 9.46%
197,268 $114 Million
Q4 2022

Feb 13, 2023

BUY
$484.71 - $571.37 $2.02 Million - $2.38 Million
4,173 Added 1.95%
217,881 $120 Million
Q3 2022

Nov 09, 2022

BUY
$507.19 - $604.49 $901,783 - $1.07 Million
1,778 Added 0.84%
213,708 $108 Million
Q2 2022

Aug 11, 2022

SELL
$500.9 - $612.21 $1.65 Million - $2.02 Million
-3,295 Reduced 1.53%
211,930 $115 Million
Q1 2022

Apr 27, 2022

SELL
$524.0 - $644.92 $9.81 Million - $12.1 Million
-18,724 Reduced 8.0%
215,225 $127 Million
Q4 2021

Feb 09, 2022

SELL
$569.0 - $667.24 $2.63 Million - $3.09 Million
-4,627 Reduced 1.94%
233,949 $156 Million
Q3 2021

Oct 28, 2021

SELL
$509.53 - $609.78 $11.9 Million - $14.2 Million
-23,290 Reduced 8.89%
238,576 $136 Million
Q2 2021

Jul 15, 2021

BUY
$441.0 - $508.24 $1.57 Million - $1.81 Million
3,571 Added 1.38%
261,866 $132 Million
Q1 2021

Apr 23, 2021

SELL
$439.85 - $518.83 $1.85 Million - $2.18 Million
-4,195 Reduced 1.6%
258,295 $118 Million
Q4 2020

Feb 09, 2021

BUY
$435.06 - $527.66 $1.2 Million - $1.46 Million
2,760 Added 1.06%
262,490 $122 Million
Q3 2020

Nov 12, 2020

BUY
$359.77 - $441.52 $482,091 - $591,636
1,340 Added 0.52%
259,730 $115 Million
Q2 2020

Aug 14, 2020

BUY
$275.2 - $362.34 $2.68 Million - $3.52 Million
9,721 Added 3.91%
258,390 $93.6 Million
Q1 2020

May 13, 2020

BUY
$255.3 - $340.05 $4.93 Million - $6.57 Million
19,311 Added 8.42%
248,669 $70.5 Million
Q4 2019

Feb 13, 2020

SELL
$271.93 - $328.04 $1.02 Million - $1.23 Million
-3,760 Reduced 1.61%
229,358 $74.5 Million
Q3 2019

Nov 12, 2019

BUY
$268.46 - $305.43 $11.3 Million - $12.9 Million
42,276 Added 22.15%
233,118 $67.9 Million
Q2 2019

Aug 14, 2019

SELL
$257.51 - $295.55 $4.23 Million - $4.85 Million
-16,413 Reduced 7.92%
190,842 $56 Million
Q1 2019

May 13, 2019

BUY
$212.17 - $273.72 $15.9 Million - $20.6 Million
75,131 Added 56.86%
207,255 $56.7 Million
Q4 2018

Feb 13, 2019

BUY
$208.47 - $251.98 $23.4 Million - $28.3 Million
112,165 Added 561.98%
132,124 $29.6 Million
Q3 2018

Nov 13, 2018

BUY
$205.57 - $244.32 $1.01 Million - $1.2 Million
4,894 Added 32.49%
19,959 $4.87 Million
Q2 2018

Aug 10, 2018

BUY
$203.14 - $219.53 $2.12 Million - $2.29 Million
10,425 Added 224.68%
15,065 $3.12 Million
Q1 2018

May 11, 2018

SELL
$192.98 - $224.11 $592,834 - $688,465
-3,072 Reduced 39.83%
4,640 $959,000
Q4 2017

Feb 13, 2018

BUY
$182.03 - $200.37 $158,184 - $174,121
869 Added 12.7%
7,712 $1.46 Million
Q3 2017

Nov 14, 2017

SELL
$171.74 - $194.04 $60,109 - $67,914
-350 Reduced 4.87%
6,843 $1.3 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,193
7,193 $1.26 Million

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $241B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Compagnie Lombard Odier S Cm A Portfolio

Follow Compagnie Lombard Odier S Cm A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Compagnie Lombard Odier S Cm A, based on Form 13F filings with the SEC.

News

Stay updated on Compagnie Lombard Odier S Cm A with notifications on news.